Related Experiment Video

Updated: Jun 18, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Suppression of cancer cell growth by promoting cyclin D1 degradation

Jing Shan1, Wenhui Zhao, Wei Gu

  • 1Institute for Cancer Genetics and Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, 1130 St. Nicholas Avenue, New York, NY 10032, USA.

Molecular Cell
|November 18, 2009
PubMed

Insights

Researchers identified USP2 as a deubiquitinase that stabilizes cyclin D1, a protein linked to cancer. Targeting USP2 effectively halts the growth of specific cancer cells dependent on cyclin D1.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin D1 proto-oncoprotein regulates cell-cycle progression.
  • Overexpression of cyclin D1 is associated with various cancers.
  • Understanding cyclin D1 regulation is crucial for cancer therapy.

Purpose of the Study:

  • To identify specific deubiquitinases (DUBs) that target cyclin D1.
  • To elucidate the role of USP2 in regulating cyclin D1 stability.
  • To evaluate USP2 as a potential therapeutic target in cyclin D1-dependent cancers.

Main Methods:

  • Screening of a deubiquitinase library using ubiquitinated cyclin D1 as a substrate.
  • Co-immunoprecipitation assays to confirm USP2-cyclin D1 interaction.
  • USP2 knockdown experiments in human cancer cell lines.

Main Results:

  • USP2 was identified as a specific deubiquitinase for cyclin D1.
  • USP2 directly interacts with cyclin D1, stabilizing it by inhibiting ubiquitin-dependent degradation.
  • USP2 knockdown destabilized cyclin D1, inducing growth arrest in cyclin D1-dependent cancer cells.
  • Inactivation of USP2 had minimal effects on normal fibroblasts or cancer cells not expressing cyclin D1.

Conclusions:

  • USP2 plays a critical role in stabilizing cyclin D1.
  • Targeting USP2 is a promising strategy for inducing growth suppression in cancers reliant on cyclin D1.
  • USP2 inhibition offers a potential therapeutic avenue for specific oncogenic pathways.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...